Co-Diagnostics, Inc. (CODX) Operating Margin
- Operating margin · 12 months: Value -6787.60%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -6787.60% | Operating income / revenue. Period ending 2026-06-30. $-48.96M ÷ $721.39K × 100 ≈ -6787.60% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -48.96M USD | Operating Income (Loss) |
| Revenue | 721.39K USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | 19.67M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-48.96M | $721.39K | (m) | $19.67M | (m) | -6787.60% |
| 2026-03-31 | $-50.82M | $718.17K | (m) | $20.20M | (m) | -7076.61% |
| 2025-12-31 | $-50.17M | $622.49K | (m) | $19.14M | (m) | -8058.83% |
| 2025-09-30 | $-35.53M | $507.89K | (m) | $18.85M | (m) | -6995.70% |
| 2025-06-30 | $-38.75M | $1.00M | (m) | $19.24M | (m) | -3861.06% |
| 2025-03-31 | $-38.37M | $3.50M | (m) | $20.17M | (m) | -1097.15% |
| 2024-12-31 | $-40.08M | $3.92M | (m) | $20.98M | (m) | -1023.75% |
| 2024-09-30 | $-40.00M | $7.32M | (m) | $22.35M | (m) | -546.37% |
| 2024-06-30 | $-38.70M | $9.14M | (m) | $23.26M | (m) | -423.56% |
| 2024-03-31 | $-43.01M | $6.68M | (m) | $23.63M | (m) | -644.14% |
| 2023-12-31 | $-42.71M | $6.81M | (m) | $22.96M | (m) | -626.92% |
| 2023-09-30 | $-57.00M | $4.66M | (m) | $21.52M | (m) | -1223.66% |
| 2023-06-30 | $-54.60M | $7.30M | (m) | $20.77M | (m) | -748.41% |
| 2023-03-31 | $-46.75M | $12.12M | (m) | $18.68M | (m) | -385.73% |
| 2022-12-31 | $-26.98M | $34.22M | (m) | $17.44M | (m) | -78.85% |
| 2022-09-30 | $9.45M | $53.22M | (m) | $14.88M | (m) | 17.76% |
| 2022-06-30 | $29.62M | $78.22M | (m) | $15.74M | (m) | 37.86% |
| 2022-03-31 | $45.55M | $100.56M | (m) | $16.52M | (m) | 45.30% |
| 2021-12-31 | $46.06M | $97.89M | (m) | $14.96M | (m) | 47.06% |
| 2021-09-30 | $51.79M | $104.63M | (m) | $13.89M | (m) | 49.49% |
| 2021-06-30 | $50.19M | $96.35M | (m) | $8.92M | (m) | 52.10% |
| 2021-03-31 | $53.11M | $93.03M | (m) | $5.00M | (m) | 57.09% |
| 2020-12-31 | $41.69M | $74.55M | (m) | $3.19M | (m) | 55.93% |
| 2020-09-30 | $24.04M | $47.52M | (m) | $2.45M | (m) | 50.60% |
| 2020-06-30 | $7.98M | $25.74M | (m) | $1.86M | (m) | 31.02% |
| 2020-03-31 | $-5.72M | $1.76M | (m) | $1.42M | (m) | -325.05% |
| 2019-12-31 | $-5.89M | $214.97K | (m) | $1.37M | (m) | -2741.61% |
| 2019-09-30 | $-6.09M | $117.23K | (m) | $1.37M | (m) | -5197.94% |
| 2019-06-30 | $-6.11M | $85.49K | (m) | $1.37M | (m) | -7143.60% |
| 2019-03-31 | $-6.09M | $33.62K | (m) | $1.41M | (m) | -18131.42% |
| 2018-12-31 | $-6.12M | $39.91K | (m) | $1.36M | (m) | -15328.65% |
| 2018-09-30 | $-5.79M | (m) | (m) | $1.27M | (m) | (m) |
| 2018-06-30 | $-5.93M | (m) | (m) | $1.21M | (m) | (m) |
| 2018-03-31 | $-5.28M | (m) | (m) | $1.03M | (m) | (m) |
| 2017-12-31 | $-4.56M | (m) | (m) | $1.00M | (m) | (m) |
| 2017-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $-1.69M | (m) | (m) | $731.47K | (m) | (m) |
| 2016-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |